期刊文献+

细菌内同源重组快速构建和制备表达β-半乳糖苷酶的重组腺病毒 被引量:17

The construction of recombinant adenoviral plasmid by homologous recombination in bacteria and the preparation of recombinant adenovirus expressing β-galactosidase
下载PDF
导出
摘要 目的 :利用细菌内同源重组快速构建重组腺病毒质粒和制备重组腺病毒。方法 :制备感受态BJ5 183,将pAdEasy - 1转化BJ5 183,制备含 pAdEasy - 1的BJ5 183感受态 ,将线性化的 pShuttle -CMV -LacZ转化含 pAdEasy- 1的BJ5 183感受态菌。采用细菌中同源重组法构建重组腺病毒质粒 pAdEasy - 1-LacZ。pAdEasy - 1-LacZ用PacⅠ线性化后 ,再用LipoVec介导其转染至AD2 93细胞内包装扩增出重组腺病毒颗粒 ,采用CsCl密度梯度离心法纯化重组腺病毒AdEasy - 1-LacZ。采用X - gal染色观察LipoVec介导的重组腺病毒质粒的转染效果及病毒包装情况。将纯化的AdEasy - 1-LacZ转染HVSMC ,X -gal染色观察基因转染效率及基因表达情况。 结果 :pShuttle -CMV -LacZ成功地转化了含 pAdEasy - 1的BJ5 183,并在其内发生了同源重组。X - gal染色证实了 pAdEasy - 1-LacZ转染AD2 93后 ,产生了重组腺病毒AdEasy - 1-LacZ。病毒滴度为 3.9× 10 12 pfu/ml。AdEasy - 1-LacZ转染HVSMC后 ,β -gal在HVSMC中得到了有效表达。 结论 :细菌内同源重组法是一种快速构建重组腺病毒质粒的方法 ,AdEasy - 1-LacZ的制备为基因治疗研究提供了一良好对照载体。 Objective To construct recombinant adenoviral plasmid containing β-galactosidase cDNA using homologous recombination in bacteria and to prepare recombinant adenovirus particles expressing β-galactosidase. Methods Adenoviral backbone plasmid was transformed into competent BJ5183 and the competent BJ5183 transformed with pAdEasy-1 was prepared. The linearized pShuttle-CMV-LacZ with PmeⅠdigestion and CIAP dephosphorylation was transformed into the competent BJ5183 transformed with pAdEasy-1. The identified recombinant adenoviral plasmid pAdEasy-1-LacZ was digested with PacⅠ and transfected into AD293 cells with cationic liposome LipoVec to package recombinant adenovirus particles AdEasy-1-LacZ. AdEasy-1-LacZ was amplified by repeated rounds of infection of AD293 cells with supernatant of the recombinant adenovirus. AdEasy-1-LacZ was purified with CsCl density gradient ultracentrifugation. The purified AdEasy-1-LacZ was transfected into human vascular smooth muscle cells(HVSMC). X-gal staining was performed to monitor the expression of β-galactosidase gene.Results pShuttle-CMV-LacZ was successfully transformed into competent BJ5183 transformed with pAdEasy-1 and homologous recombination between pAdEasy-1 and pShuttle-CMV-LacZ within BJ5183 bacteria took place. LipoVec transfected PacⅠ-digested pAdEasy-1-LacZ into AD293 cells. X-gal staining confirmed the packaging of recombinant adenovirus AdEasy-1-LacZ within AD293 cells and the expression of β-galactosidase in HVSMC,respectively. The viral titer was 3.9×10 12pfu/ml.Conclusion Homologous recombination between adenoviral backbone plasmid and shuttle plasmid containing exogenous gene within bacteria should expedite the process of generating recombinant adenoviruses and avoid the plaque purification. This system may provide the basis for construction of recombinant adenovirus expressing therapeutic gene of interest. AdEasy-1-LacZ is a useful tool in the research of safety, feasibility and the efficiency of gene transfer mediated by recombinant adenovirus.
出处 《郧阳医学院学报》 2004年第1期1-5,F002,共6页 Journal of Yunyang Medical College
基金 湖北省自然科学基金项目 (2 0 0 0J0 5 6 )
关键词 细菌 同源重组 制备 Β-半乳糖苷酶 重组腺病毒 基因治疗 homologous recombination Adenovirus gene therapy β-galactosidase
  • 相关文献

参考文献10

二级参考文献46

  • 1李尹雄 卢圣栋.核酸的分离与纯化.现代分子生物学实验技术(第一版)[M].北京:高等教育出版社,1993.147-149.
  • 2DL佩斯克特著.细胞实验指南[M].北京:科学出版社,2001.1394.
  • 3F奥斯伯 R 布伦特 RE 金斯顿 等.精编分子生物学试验指南 [M].北京:科学出版社,1999.826-830.
  • 4彭朝晖 薛京伦 徐钤 等.基因治疗-基础与临床 [M].北京:中国科学技术出版社,1992.247-258.
  • 5[1]Magovern C J, Mack CA, Zhang J, et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector[J]. Ann Thorac Surg, 1996,62(2):425~433.
  • 6[2]Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion[J]. Circulation, 1996,94(12):3 281~3 290.
  • 7[3]Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVFGF165 as sole therapy for myocardial ischemia[J]. Circulation, 1998,98(25): 2 800~2 804.
  • 8[4]Symes JF, Losordo DW, Vale PR, et al, Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J].Ann Thorac Surg, 1999, 68(3): 830~836.
  • 9[5]Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart[J]. J Thorac Cardiovasc Surg, 1998,115:168~176.
  • 10[6]Isner JM, Asahara. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization [J]. J Clin lnvest, 1999,103(9):1231~1236.

共引文献57

同被引文献116

引证文献17

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部